Neurofibromatoses

A group of disorders characterized by an autosomal dominant pattern of inheritance with high rates of spontaneous mutation and multiple neurofibromas or neurilemmomas. NEUROFIBROMATOSIS 1 (generalized neurofibromatosis) accounts for approximately 95% of cases, although multiple additional subtypes (e.g., NEUROFIBROMATOSIS 2, neurofibromatosis 3, etc.) have been described. (From Neurochirurgie 1998 Nov;44(4):267-72)

Also Known As:

Neurofibromatosis; Syndrome, Neurofibromatosis; Multiple Neurofibromas; Neurofibromatosis 3; Neurofibromatosis Syndrome; Multiple Neurofibroma; Neurofibroma, Multiple; Neurofibromas, Multiple; Neurofibromatosis 3s; Neurofibromatosis Syndromes; Neurofibromatosis Type 3s; Syndromes, Neurofibromatosis; Type 3, Neurofibromatosis; Neurofibromatosis Type 3

Neoplasms: 1361496
- Hereditary Neoplastic Syndromes: 115
  - Neurofibromatoses: 834
- Neoplasms by Histologic Type: 2
  - Nerve Tissue Neoplasms: 1
    - Nerve Sheath Neoplasms: 280
      - Neurofibroma: 865
        Neurofibromatoses: 834
Nervous System Diseases: 14737
- Neurodegenerative Diseases: 44095
  - Nervous System Heredodegenerative Disorders: 62
    - Neurofibromatoses: 834
- Neurocutaneous Syndromes: 269
  - Neurofibromatoses: 834
Congenital, Hereditary, and Neonatal Diseases and Abnormalities: 960
- Inborn Genetic Diseases: 12342
  - Hereditary Neoplastic Syndromes: 115
    - Neurofibromatoses: 834
  - Nervous System Heredodegenerative Disorders: 62
    - Neurofibromatoses: 834

Jose M Carazo Selected Research

Jose M Carazo Research Topics

Disease

Drug/Important Bio-Agent (IBA)